Poster 1439 - Ovarian & EndometrialSimilar data on the precision of the drug getting in to tumor cells, efficacy and safety. Seems to work really well for endometrial cancers. For Ovarian, really well on one line and about the same for the SKOV-3 line but I guess safety and only 1/4 the dose means you could use longer and more. Not really sure of that last statement.
All in, this is data we sort of knew but is good to see it in charts. Unfortunately Christian did not do the video, Michel Demule did and he has a very thick accent. He looked like he had just woken up or something, hair in a mess. But you could follow it since he just repeated all the chart bullet points.